Lawyers Andreas Wildi

Andreas Wildi

Andreas Wildi

Partner
Dr. med. et lic. iur. HSG, Attorney at Law

vCard

Location

Contact

Direct phone: +41 58 658 29 15
andreas.wildi@walderwyss.com

Curriculum Vitae

Areas of activity: Healthcare & Life Sciences Public Law & Litigation Litigation

Andreas Wildi, born 1972, is a medical doctor and an attorney at law.

He advises and represents companies, associations and NGOs in the life sciences and healthcare sector.

His main focus is on reimbursement and pricing as well as regulatory affairs relating to pharmaceuticals and medical devices.

Andreas Wildi studied medicine at the University of Zurich and received his doctorate (Dr. med. / MD). While working part-time as a doctor in a hospital, in international rescue services and assisting / substituting general practitioners, he completed his law studies at the University of St. Gallen HSG (lic. iur. HSG). Before being admitted to the bar, Andreas Wildi was a clerk at a Cantonal Court and a trainee in a recognized Zurich business law firm. From his first position as an attorney at law in a large Zurich business law firm, Andreas Wildi was asked to work for the Swiss Government, where he led the pharmaceutical reimbursement & pricing unit in the Federal Office of Public Health BAG. Andreas Wildi deepened his market access expertise internationally as EMEA market access law director for a large multinational life sciences company. Andreas Wildi has been a partner at Walder Wyss in Zurich and Berne since 2015.

Andreas Wildi works in German, English and French. He is admitted to the bar before all courts in Switzerland and is a guest lecturer in pharmaceutical law at the Law Faculty of the University of Lucerne and at the University of Bern’s KPM Center for Public Management.

Walder Wyss successfully represented a pharmaceutical company before the Federal Supreme Court

Legalcommunity.ch Awards: Walder Wyss Receives Awards as Market Leading Firm and Labour Law Firm of the Year

Bavarian Nordic Acquires Emergent BioSolutions’ Travel Vaccines Portfolio

21 February 2023

Differentiated EAE examination of Herbal Medicinal Products

5 February 2024

Swiss pharmaceutical reimbursement and pricing: Ordinance Law Changes (KVV/KLV) as of January 2024: Today's Decision by the Swiss Federal Council (Bundesrat)

21 September 2023

Triennial review of medicines’ SL prices: Lessons learned from appeals won against the FOPH

The Revised Law on Human Genetic Testing

Access to unapproved/non-listed drugs: A veritable maze

31 January 2023

Pharmaceutical Advertising 2022 - Switzerland

Commentary on Art. 5, 6 und 7a HMG

30 November 2021

Entry into force of the revised Swiss Medical Devices Ordinance and its implications for the medtech industry

The Life Sciences Law Review Chapter 24 - Switzerland

Pharmaceutical Advertising – Switzerland

Liberté de choix de la thérapie vs principe du caractère économique dans le domaine de la liste des spécialités

19 November 2020

Therapiewahlfreiheit vs. Wirtschaftlichkeitsgebot im Bereich der Spezialitätenliste

19 November 2020

Update: Postponement of EU Medical Device Regulation implementation due to COVID-19

The Life Sciences Law Review Chapter 28 - Switzerland

Postponement of EU Medical Device Regulation implementation due to COVID-19

Art. 40, 52, 52a KVG

27 January 2020

Handbook on Foodstuffs and Utility Articles law

31 December 2019

The distinction between food and therapeutic products

31 December 2019

Life Science Law Update

17 December 2019

Life Science Law Update

21 November 2019

Life Science Law Update

21 October 2019

Life Science Law Update

19 September 2019

Life Science Law Update

The Life Sciences Law Review Chapter 29 - Switzerland

Pharmaceutical Advertising - Switzerland

Medicines are not a rare commodity

Chapter 16: Switzerland

31 December 2017

Chapter 16: Switzerland

31 December 2016

Limitation of medicines in health insurance law: where is the boundary with rationing exceeded?

30 November 2016

Do high medicine prices restrict doctors" therapeutic freedom?

31 December 2015

Compendium of contracts in Pharma and Life Sciences, chapter with regard to legal specifics in Switzerland

15 December 2015

Therapeutic freedom despite contraindications?

31 October 2015

Side effects of a Federal Government decision, commentary in the "NZZ" to changes in the Swiss pharmaceutical reimbursement & pricing scheme

A guide for medical doctors, pharmacists, authorities and payers

15 December 2013

Recognitions

Chambers Europe 2023

Legal 500 recommended lawyer 2023

Who's Who Legal_Recognised

Best Lawyers 2024 - Andreas Wildi

Other lawyers

Technically necessary cookies

Essential technical cookies are necessary for the flawless functioning of our website and cannot be disabled.
Cookies for statistics

Analytical cookies enable us to count visits and traffic sources, allowing us to measure and enhance the performance of our website. They assist us in answering questions such as which pages are the most popular, which are the least used, and how visitors navigate the website. All information collected by these cookies is aggregated and therefore anonymous.
Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.

Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.